Consolidated Statement of Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Common stock, shares at Oct. 31, 2017		37,508,877
Stockholders' equity, value at Oct. 31, 2017	$ 407,692,000	$ 375,000	$ 255,719,000	$ 226,549,000	$ (25,076,000)	$ (49,875,000)
Treasury shares (in shares) at Oct. 31, 2017						(2,670,743)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	26,553,000		(473,000)	26,553,000		$ 25,340
Foreign currency translation adjustment (net of taxes)	(6,640,000)				(6,640,000)
Change in pension from net unamortized gain	1,011,000				1,011,000
Common dividends ($0.16 per share)	(7,020,000)			(7,020,000)
Stock repurchased during period, shares (in shares)						(1,900,000)
Stock repurchased during period, value	32,034,000					$ 32,034,000
Stock-based compensation activity:
Expense related to stock-based compensation	1,874,000		1,874,000
Stock options exercised	$ 4,746,000		(149,000)	(2,141,000)		$ 7,036,000
Stock options exercised (in shares)	377,218					377,218
Restricted stock awards granted	$ 0		(1,371,000)			$ 1,371,000
Restricted stock awards granted (in shares)						73,400
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants						$ 473,000
Recognition of unrecognized tax benefit	0
Other (in shares)		(75,060)
Other	(960,000)	$ (1,000)	(922,000)	(37,000)
Common stock, shares at Oct. 31, 2018		37,433,817
Stockholders' equity, value at Oct. 31, 2018	395,222,000	$ 374,000	254,678,000	243,904,000	(30,705,000)	$ (73,029,000)
Treasury shares (in shares) at Oct. 31, 2018						(4,094,785)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(46,730,000)			(46,730,000)
Foreign currency translation adjustment (net of taxes)	1,864,000				1,864,000
Change in pension from net unamortized gain	(4,976,000)				(4,976,000)
Common dividends ($0.16 per share)	$ (10,644,000)			(10,644,000)
Stock repurchased during period, shares (in shares)	(583,398)					(583,398)
Stock repurchased during period, value	$ 9,551,000					$ 9,551,000
Stock-based compensation activity:
Expense related to stock-based compensation	2,045,000		2,045,000
Stock options exercised	$ 3,288,000	$ 1,000		(322,000)		$ 3,609,000
Stock options exercised (in shares)	204,770					204,770
Restricted stock awards granted	$ 0		(1,720,000)	(505,000)		$ 2,225,000
Restricted stock awards granted (in shares)						124,800
Other (in shares)		(63,415)
Other	$ (331,000)	$ (1,000)	(330,000)
Common stock, shares at Oct. 31, 2019	37,370,402	37,370,402
Stockholders' equity, value at Oct. 31, 2019	$ 330,187,000	$ 374,000	254,673,000	185,703,000	(33,817,000)	$ (76,746,000)
Treasury shares (in shares) at Oct. 31, 2019	(4,491,429)					(4,348,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 38,496,000			38,496,000
Foreign currency translation adjustment (net of taxes)	1,078,000				1,078,000
Change in pension from net unamortized gain	(285,000)				(285,000)
Common dividends ($0.16 per share)	$ (10,534,000)			(10,534,000)
Stock repurchased during period, shares (in shares)	(450,000)					(450,000)
Stock repurchased during period, value	$ 7,233,000					$ 7,233,000
Stock-based compensation activity:
Expense related to stock-based compensation	879,000		879,000
Stock options exercised	$ 3,625,000		66,000	$ (242,000)		$ 3,801,000
Stock options exercised (in shares)	215,733					215,733
Restricted stock awards granted	$ 0		(1,212,000)			$ 1,118,000
Restricted stock awards granted (in shares)				94,000		63,400
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants			(495,000)			$ 28,051
Recognition of unrecognized tax benefit	0					495,000
Other (in shares)		(74,236)
Other	$ (454,000)	$ (1,000)	(453,000)
Common stock, shares at Oct. 31, 2020	37,296,166	37,296,166
Stockholders' equity, value at Oct. 31, 2020	$ 355,759,000	$ 373,000	$ 253,458,000	$ 213,517,000	$ (33,024,000)	$ (78,565,000)
Treasury shares (in shares) at Oct. 31, 2020	(4,348,613)					(4,491,429)